Answers are grounded in this paper and cite their sources.
Background: Inflammation and immune dysregulation contribute to the onset and progression of chronic kidney disease (CKD). Using an Adriamycin (ADR) -induced renal injury model in rats and an in vitro model of rat glomerular mesangial HBZY-1 cells, this study investigated the renoprotective effects of dioscin (Dio) and the potential signaling mechanisms involved. Methods: Dio-related and ADR-induced renal injury-related targets were retrieved from public databases, and their overlapping genes were subjected to Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses. ADR-induced renal injury models were established in rats and HBZY-1 cells which were then treated with Dio. Renal function; histopathology; inflammatory mediators, including tumor necrosis factor alpha (TNF-α) and interleukin-6 (IL-6); injury markers, including inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2); pyroptosis-related markers, including IL-1β, IL-18, and cleaved caspase-1 (c-caspase-1); and Toll-like receptor 4 (TLR4)/myeloid differentiation primary response 88 (MyD88)/nuclear factor kappa B (NF-κB)/Nucleotide-binding oligomerization domain, leucine-rich repeat and pyrin domain-containing protein 3 pathway (NLRP3) activity were assessed using biochemical assays, transmission electron microscopy, enzyme-linked immunosorbent assay, Western blotting, quantitative reverse transcription-polymerase chain reaction, and immunofluorescence staining. Results: Network pharmacology identified 21 candidate therapeutic targets of Dio in ADR-induced renal injury. The enriched biological processes and pathways were predominantly related to inflammatory and immune signaling, with the TLR4/MyD88/NF-κB axis and NLRP3 inflammasome identified as central components. In rats, Dio increased serum albumin (ALB) and transcutaneous glomerular filtration rate; reduced proteinuria, serum creatinine (Scr), and cystatin C (CysC); and attenuated renal ultrastructural injury. In rat kidneys and ADR-treated HBZY-1 cells, Dio reduced the levels of TNF-α, IL-6, iNOS, COX-2, IL-1β, IL-18, NLRP3, and c-caspase-1. It also suppressed TLR4/MyD88/NF-κB/NLRP3 signaling and decreased the nuclear accumulation of NF-κB p65. Conclusion: Dio attenuated ADR-induced renal dysfunction, inflammation, tissue injury, and pyroptosis in the experimental models. These findings suggest that suppression of the TLR4/MyD88/NF-κB/NLRP3 pathway contributes to the renoprotective effects of Dio.
No takes yet. Share an insight, caveat, or question.
He et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: